Supporting the mental health and wellbeing of over 4 million people in Australia living with cardiovascular disease (CVD) is crucial to them avoiding further heart attacks or strokes.

The U.S. obesity epidemic continues to have profound impacts on individuals’ health and socioeconomic well-being

Medicine is a constantly evolving science where small changes can have a huge impact on the lives of patients. When it comes to a cancer diagnosis and treatment, every minute counts. According to European Commission estimates, the cancer incidence by 2040 will impact just over three million people a year.

In 2019, there were almost 14 thousand diabetes-related deaths in the UK. That number looks set to rise. Britain currently has 4.3 million registered diabetics, but new analysis from London Medical Laboratory has revealed there are likely to be over one million Brits suffering from undiagnosed type 2 diabetes.

A world-first discovery has revealed special immune cells called ‘killer T cells’ in older adults, directed against influenza viruses, closely resemble those found in newborns and children, but struggle to recognise infected cells – a finding that unlocks the potential for the development of better vaccines and therapies tailored to different age groups.

A new study finds that consanguinity – unions between close relatives – may increase the risk of common diseases such as type 2 diabetes and post-traumatic stress disorder (PTSD).

When Kylie Jenner famously admitted that her signature pout was the result of lip fillers, there was a significant increase in interest and uptake of the cosmetic procedure. That’s the power of social media.

University of Toronto researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed.

The company has unveiled a zero-tobacco stick for use with its 'heat-not-burn' device IQOS, which may help the company avoid tax and other regulations in some markets.
Reuters Health Information

Johnson & Johnson announced it would not enforce any of its patents for a key tuberculosis drug in 134 low- and middle-income countries.